PetMed Express (PETS) Stock Price, News & Analysis

Company Overview

PetMed Express, Inc., doing business as PetMeds, is an online retailer of prescription and nonprescription medications and health products for dogs, cats and other household pets. The company offers products used to treat or prevent conditions such as allergies, infections, parasites and chronic illnesses, including prescription medicines, flea and tick treatments, heartworm preventatives, supplements and other animal-health products.

In addition to medications, PetMeds sells pet food, treats, vitamins, wellness products and selected supplies. Customers can place orders through the company’s website and other direct-to-consumer channels, with prescription orders generally requiring authorization from a licensed veterinarian. PetMeds primarily serves pet owners in the United States.

Founded in 1996 and previously known as 1-800-PetMeds, the company has built its business around convenient home delivery and consumer access to pet-health products. PetMed Express is headquartered in Delray Beach, Florida, and its common stock trades on the Nasdaq Capital Market under the symbol PETS.

Key Stats

• Today's Range: $1.16 to $1.22
• 50-Day Range: $1.15 to $1.89
• 52-Week Range: $1.15 to $4.10
• Volume: 62,026 shs
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $1.40
• Consensus Rating: Strong Sell

PetMed Express Stock Analysis - MarketRank™

PetMed Express scored higher than 41% of companies evaluated by MarketBeat, and ranked 392nd out of 487 stocks in the consumer discretionary sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.6 / 5
• Analyst Rating: Strong Sell

Consensus Rating

PetMed Express has received a consensus rating of Strong Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 3 sell ratings.

Upside Potential

PetMed Express has a consensus price target of $1.40, representing about 18.6% upside from its current price of $1.18.

Amount of Analyst Coverage

PetMed Express has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for PetMed Express are expected to grow in the coming year, from ($0.50) to ($0.35) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of PetMed Express is -0.86, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of PetMed Express is -0.86, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

PetMed Express has a P/B Ratio of 0.87. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

4.19% of the float of PetMed Express has been sold short.

Short Interest Ratio / Days to Cover

PetMed Express has a short interest ratio ("days to cover") of 7.4.

Change versus previous month

Short interest in PetMed Express has recently increased by 29.61%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

PetMed Express does not currently pay a dividend.

Dividend Growth

PetMed Express does not have a long track record of dividend growth.

News and Social Media

• Score: 3.1 / 5
• News Sentiment: 0.91

News Sentiment

PetMed Express has a news sentiment score of 0.91. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.52 average news sentiment score of Consumer Discretionary companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for PetMed Express this week, compared to 2 articles on an average week.

Search Interest

6 people have searched for PETS on MarketBeat in the last 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, PetMed Express insiders have not sold or bought any company stock.

Percentage Held by Insiders

1.30% of the stock of PetMed Express is held by insiders.

Percentage Held by Institutions

73.33% of the stock of PetMed Express is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/13/2026
• Today: 10/27/2026
• Next Earnings (Estimated): 12/18/2026
• Fiscal Year End: 3/31/2027

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Consumer Discretionary
• Industry: Specialty Retail
• Sub-Industry: Other Specialty Retail
• Current Symbol: NASDAQ:PETS
• CIK: 1040130
• Web: www.petmeds.com
• Phone: (561) 426-4444
• Fax: 561-526-4445
• Employees: 189
• Year Founded: 1996

Price Target and Rating

• Average Price Target for PetMed Express: $1.40
• High Price Target: $1.40
• Low Price Target: $1.40
• Potential Upside/Downside: +18.6%
• Consensus Rating: Strong Sell
• Rating Score (0-4): 1.00
• Research Coverage: 3 Analysts

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: 21,397,000
• Market Cap: N/A
• Optionable: Optionable
• Beta: N/A